VIP2 study

Overview of the VIP2 study (POETICS2 in UK)

VIP2 stands for Very old Intensive Care Patients study 2.
An ESICM supported study conducted from the HSRO & NAHP section in ESICM. ClinicalTrials.gov registration. Follow the VIP2-project on ResearchGate.
The VIP2-study was called the POETICS2 study in Great Britain.


Background and scope
This study sought to develop a prognostic score for specifically very old, critically ill patients  defined as patients ≥ 80 years). This was a large, prospective, multinational, multicentre study. We gathered age-specific information about the elderly patient: frailty, cognitive function, activity of daily life and co-morbidity, in addition to organ failure score. Outcomes were registered as outcome at 30 days (alive or dead) and 6 months in a sub-study. Also, an Frailty score interrater variability was recorded in a sub-study.

Recruitment of patients
The goal was to recruit 20 consecutive ICU patients ≥ 80 years, or continue for a 6 months period. Based on a previous multicentre study (the VIP1) we hoped to recruit 200-250 ICUs and 4000-5000 patients.


VIP2 coordinators


Bertrand GuidetCo-Principal Investigator of the VIP study group and French coordinatorParis, Francebertrand . guidet @ aphp . fr
Dylan deLangeThe Netherlands coordinator and Chair of ESICM HSRO sectionUtrecht, The Netherlandsd . w . delange @ umcutrecht . nl
Hans FlaattenPrincipal Investigator of the VIP study group, Past chair HSRO section,Bergen, Norwayhans . flaatten @ uib . no
Alessandro MorandiCremona, Italymorandi . alessandro @ gmail . com
Antonio ArtigasSpanish coordinatorBarcelona, Spainaartigas @ tauli . cat
Ariane BoumendilStatisticianParis, Franceariane . boumendil @ gmail . com
Brian MarshIrish coordinatorDublin, Irelandbmarsh @ mater . ie
Carole BoulangerExeter, Englandcarole . boulanger @ nhs . net
Christian JungPrinciple Investigator of the COVIP study and German coordinatorDusseldorf, Germanychristian . jung @ med . uni-duesseldorf . de
Finn AndersenNorwegian coordinatorÅlesund, Norwayfinn . h . andersen @ helse-mr . no
Ivo SolimanUtrecht, The Netherlandsi . w . soliman @ umcutrecht . nl
Jesper FjølnerCo-Principle investigator in the COVIP study, Danish coordinator, datamanagerAarhus, Denmarkjespfjoe @ rm . dk
Joerg SchefoldBern, Switzerlandjoerg . schefold @ insel . ch
Maurizio CecconiMilan, Italymaurizio . cecconi @ hunimed . eu
Michael JoannidisAustrian coordinatorInnsbruck, Austriamichael . joannidis @ i-med . ac . at
Muhammed ElhadiLybian coordinatorTripoli, Libyamuhammed . elhadi . uot @ gmail . com
Rui MorenoPortuguese coordinatorLisboa, Portugalr . moreno @ mail . telepac . pt
Sandra OeyenGhent, Belgiumsandra . oeyen @ ugent . be
Sten WaltherSwedish coordinatorLinkoping, Swedensten . walther @ telia . com
Susannah LeaverUnited Kingdom coodinatorLondon, Englandsusannahleaver @ nhs . net
Tilemachos ZafeiridisGreek coordinatorLarissa, Greecetilemachos @ hotmail . com
Wojciech SzczeklikPolish coordinatorKrakow, Polandwszczeklik @ gmail . com
Ximena WatsonLondon, Englandugm2xw @ doctors . org . uk
Yuriy NalapkoUkranian coordinatorLugansk, Ukrainenalapko @ ukr . net

VIP2 Documents

Information about the studyDownload
Letter of intentDownload
Timeline for data collectionDownload
How to perform initial “geriatric” assessmentDownload
Information to patients and care-givers (template)Download
Study protocol (version Oct. 18th 2018)Download
Paper CRF for offline patient data capture

 

 
Download

Clinical Frailty Scale (CFS)

Clinical Frailty ScaleDownload

KATZ index of Activities of Daily Living

Katz ADL index EnglishDownload
Katz ADL index GreekDownload

Data entry timeline

VIP2 site collaborators